61 Warfarin and GLP-1 Receptor Agonist Interaction Effects on Time in Therapeutic Range
Saved in:
| Main Authors: | Phillip Anjum, Mikhail Y. Akbashev, Alyssa Utz, Sydney Kisala |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-05-01
|
| Series: | Research and Practice in Thrombosis and Haemostasis |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2475037925001049 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
82 Impact of Food Insecurity on Anticoagulation Quality Among Patients Receiving Warfarin at a Safety Net Academic Center
by: Yva Gauthier, et al.
Published: (2025-05-01) -
Adverse effects of GLP – 1 Receptor Agonists
by: Anna Kasprzak, et al.
Published: (2025-02-01) -
A Comprehensive Review on the Pharmacokinetics and Drug−Drug Interactions of Approved GLP-1 Receptor Agonists and a Dual GLP-1/GIP Receptor Agonist
by: Min JS, et al.
Published: (2025-04-01) -
GLP-1 receptor agonists and pulmonary hypertension in diabetes: A promising therapeutic strategy
by: Arif Albulushi, et al.
Published: (2025-07-01) -
Oral Small-Molecule GLP-1 Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies
by: Héctor Iván Saldívar-Cerón, et al.
Published: (2025-06-01)